Executive Summary

Artificial intelligence is rapidly changing how clinical trials are designed, managed, and executed. While Electronic Data Capture (EDC) systems have traditionally focused on collecting and validating clinical trial data, a new generation of platforms is beginning to use AI to streamline study setup, reduce manual configuration, improve operational efficiency, and accelerate study startup.

For sponsors, CROs, and biotech companies, this evolution is particularly important. Database development, form creation, edit check programming, and protocol configuration have historically required significant manual effort, often adding weeks or months to study timelines.

As a result, organizations are increasingly evaluating not only the traditional capabilities of an EDC system but also its ability to leverage artificial intelligence throughout the clinical trial lifecycle. This guide compares the leading AI-powered EDC platforms available in 2026.

Why AI Is Transforming Electronic Data Capture

Traditional EDC systems were designed primarily to digitize data collection. However, many aspects of study setup remain highly manual. Clinical teams often spend considerable time on:

Designing eCRFs

Configuring databases

Creating edit checks

Implementing protocol logic

Validating study workflows

Preparing systems for user acceptance testing

Artificial intelligence introduces the possibility of accelerating these processes by analyzing study requirements and reducing repetitive manual work, providing meaningful operational advantages for sponsors and CROs.